Beijing Jingsource Pharmaceutical Technology Co., Ltd.

Beijing Jingsource Pharmaceutical Technology Co., Ltd. is located in China, with 5 active products in its catalogue. The company lists various pharmaceutical intermediates, including Entecavir intermediate 7, Entecavir intermediate 8, Entecavir monohydrate, Entecavir intermediate 4, and Entecavir intermediate 8 isomer. These products are likely classified under the HS code families for pharmaceutical intermediates, which typically range from 2901 to 2942. Buyers of these products usually require specifications, such as purity and moisture content, to ensure the quality of the intermediates.

The pharmaceutical industry in China is a significant sector, with many companies like Beijing Jingsource Pharmaceutical Technology Co., Ltd. contributing to the global supply of pharmaceutical intermediates. The country's pharmaceutical exports are subject to regulations, such as those related to the registration and licensing of pharmaceutical manufacturers. As a result, buyers should verify the supplier's compliance with these regulations and request relevant documents, such as a Good Manufacturing Practice (GMP) certificate.

Beijing Jingsource Pharmaceutical Technology Co., Ltd.'s product range includes various pharmaceutical intermediates, which are typically used in the production of active pharmaceutical ingredients (APIs). The company's catalogue includes Entecavir intermediates, which are used in the synthesis of Entecavir, an antiviral medication. Buyers of these products should request specifications, such as the intermediate's purity, moisture content, and impurity profile, to ensure the quality of the product. Additionally, buyers may want to request information on the supplier's quality control processes, such as testing and inspection procedures, to ensure that the products meet their requirements.